Project Details
Description
A Phase 2 Randomized Trial of Neoadjuvant Enoblituzumab versus Standard of Care in Men with High-Risk Localized Prostate Cancer: The Help Elucidate & Attack Longitudinally (HEAT) Prostate Cancer Randomized Study
| Status | Active |
|---|---|
| Effective start/end date | 5/10/24 → 7/4/28 |
Funding
- JOHNS HOPKINS UNIVERSITY
- MACROGENICS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.